Vertex Pharmaceuticals today announced that Medsafe has recommended the approval of ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor) for the treatment of people aged 6 years and older who have at ...

Glass tried the injections for his advanced disease, but they did not halt his vision loss. So his ophthalmologist tried ...

Although teplizumab doesn’t work for everyone and how much it delays progression varies, it has inspired new directions in ...

Innovative obesity drugs. Quantum computing bits. A cystic fibrosis treatment. The scientists behind these discoveries could ...

Sterling Glass had many health problems as a child—swollen feet, night sweats, nausea and vomiting, unquenchable thirst, and ...

The girl was diagnosed with stage 2 of the disease, a status that meant her own immune system was making at least two types ...

Platformization” eventually comes to every high-profile IT space as the number of tools and amount of complexity increases.

Maren Denison, third-year student at the University of Iowa, was in sixth grade when she found out her lung function had ...

The company plans to deploy the primary capital to strengthen research and development and manufacturing, step up brand building, and build out a health-tech ecosystem around its products ...

Researchers have engineered a novel M6L4 octahedral molecular cage by integrating photoactive cyclometalated platinum(II) ...

The new paid service replaces the Agentspace app launched in 2024 and grounds the AI assistant in a range of business data.

Researchers from Harvard’s Department of Human Evolutionary Biology found that educated children perform better on psychological tests measuring executive function abilities, challenging the accuracy ...